2 completed, 1 active not recruiting, 1 recruiting. 4 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Completed 2, Active not recruiting 1, Recruiting 1 |
| Phase 2 | 1 | Active not recruiting 1 |
Follow Dementia, Mild: new trials by email Literature Review of Dementia, Mild trials Research Report on Dementia, Mild
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Mazdutide in Type 2 Diabetes With Early-Stage Cognitive Impairment (LIGHT-COG Study) Mazdutide, Placebo - Dementia, Mild, Mild Cognitive Impairment | Phase 3 | Recruiting | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | 420 | 2025-09-27 | 2026-09-02 |
| Effect of 10 mg Xanamem on Dementia Due to Alzheimer's Disease Xanamem, Placebo - Dementia Moderate, Dementia, Mild | Phase 2 / Phase 3 | Active not recruiting | Actinogen Medical | 247 | 2024-04-12 | 2026-10-21 |
| Precision Medicine Approach for Early Dementia & Mild Cognitive Impairment Precision Medicine Approach, Hormones and Medications tailored to lab tests, combined with devices that support stress management and brain exercises, Standard-of-Care - Mild Cognitive Impairment, Dementia, Mild | Phase 3 | Completed | Alzheimer's Prevention and Reversal Project, Inc. | 73 | 2023-07-31 | 2026-02-18 |
| Effects of Multimodal Cognitive Enhancement Therapy (MCET) for Ealy Dementia Period I MCET (8 wks), Washout (4 wks), Period II MCET (8 wks) - Mild Cognitive Impairment, Dementia, Mild | Phase 3 | Completed | Ki Woong Kim | 64 | 2014-02-01 | 2015-07-28 |
Dementia (4) · Lymphoma, Follicular (4) · Cognitive Dysfunction (3) · Alzheimer Disease (2) · Anomia (1) · Diabetes Mellitus, Type 2 (1)
Brain Diseases (4) · Central Nervous System Diseases (4) · Hemic and Lymphatic Diseases (4) · Immune System Diseases (4) · Immunoproliferative Disorders (4) · Lymphatic Diseases (4) · Lymphoma (4) · Lymphoma, Non-Hodgkin (4) · Lymphoproliferative Disorders (4) · Mental Disorders (4) · Neoplasms (4) · Neoplasms by Histologic Type (4) · Nervous System Diseases (4) · Neurocognitive Disorders (4) · Cognition Disorders (3)
Exercise (1) · Hormones (1) · Standard of Care (1) · UE2343 (1) · mazdutide (1)
Actinogen Medical (1) · Alzheimer's Prevention and Reversal Project, Inc. (1) · Ki Woong Kim (1) · The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School (1)
United States (2) · Australia (1) · China (1) · South Korea (1)
Dale Bredesen, MD (1) · Kat Toups, MD (1) · Ki Woong Kim, M.D., Ph.D. (1) · Yan Bi, MD, PhD (1)